Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

MDL Panel statistics on mass torts

By Bexis on December 8, 2006
Email this postTweet this postLike this postShare this post on LinkedIn

There’s a noteworthy article in the December 2006 issue of The American Lawyer about the supposed death of mass torts. The entire article is interesting, but here’s the statistical analysis of the MDL Panel that caught our eye:
“In the panel’s first 15 years of existence, the judges heard arguments to transfer 32 mass torts matters. They denied the transfer of 19 of them–including several proposed asbestos MDLs and at least a half-dozen pharmaceutical cases–leaving the cases to be litigated in multiple courtrooms. Then trends changed. As mass tort litigation burgeoned, the MDL panel judges not only heard more requests, they also transferred a higher percentage of them. From 1986 through 2000, the panel denied only nine of the 68 MDL motions it heard. And in the last six years, only six of the 62 cases the panel considered were denied MDL status.”
Clients often ask about the statistical tendencies of the MDL Panel; it’s nice to have the numbers gathered in one place in print.

Photo of Bexis Bexis

JAMES M. BECK is Reed Smith’s only Senior Life Sciences Policy Analyst, resident in the firm’s Philadelphia office. He is the author of, among other things, Drug and Medical Device Product Liability Handbook (2004) (with Anthony Vale). He wrote the seminal law review…

JAMES M. BECK is Reed Smith’s only Senior Life Sciences Policy Analyst, resident in the firm’s Philadelphia office. He is the author of, among other things, Drug and Medical Device Product Liability Handbook (2004) (with Anthony Vale). He wrote the seminal law review article on off-label use cited by the Supreme Court in Buckman v. Plaintiffs Legal Committee. He has written more amicus briefs for the Product Liability Advisory Council than anyone else in the history of the organization, and in 2011 won PLAC’s highest honor, the John P. Raleigh award. He has been a member of the American Law Institute (ALI) since 2005. He is the long-time editor of the newsletter of the ABA’s Mass Torts Committee.  He is vice chair of the Class Actions and Multi-Plaintiff Litigation SLG of DRI’s Drug and Device Committee.  He can be reached at jmbeck@reedsmith.com.  His LinkedIn page is here.

Read more about BexisEmailJames's Linkedin Profile
Show more Show less
  • Posted in:
    Class Action & Mass Torts
  • Blog:
    Drug & Device Law
  • Organization:
    Drug & Device Law Blogging Team
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo